Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Sherwin Stephen A
Over the trailing 90 days, Sherwin Stephen A (Director at NEUROCRINE BIOSCIENCES INC) traded $5.7M of stock (net selling $2.5M) across 2 companies, per 13 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 13 transactions · CIK 1079462
- Net activity
- −$2.5M ($1.6M bought · $4.1M sold)
By Company (Trailing 90 Days)
Transactions (13)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-09 | BIIB | Buy | 1.5K | $0 | Grant, award or other acquisition |
| 2026-06-05 | NBIX | Sell | 10.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-05 | NBIX | Sell | 15.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-05 | NBIX | Buy | 10.0K | $798K | Exercise or conversion of derivative security |
| 2026-06-05 | NBIX | Sell | 7.9K | $1.3M | Open market or private sale |
| 2026-06-05 | NBIX | Buy | 15.0K | $805K | Exercise or conversion of derivative security |
| 2026-06-05 | NBIX | Sell | 6.9K | $1.1M | Open market or private sale |
| 2026-06-05 | NBIX | Sell | 2.5K | $419K | Open market or private sale |
| 2026-06-05 | NBIX | Sell | 5.8K | $971K | Open market or private sale |
| 2026-06-05 | NBIX | Sell | 1.8K | $308K | Open market or private sale |
| 2026-05-27 | NBIX | Buy | 2.6K | $0 | Grant, award or other acquisition |
| 2026-05-21 | NBIX | Sell | 3.3K | $0 | Exercise or conversion of derivative security |
| 2026-05-21 | NBIX | Buy | 3.3K | $0 | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Sherwin's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.